Chemogenics Biopharma Llc
- View government funding actions
- Research Triangle Park, NC 277090002
- Phone: 919-308-1341
- Corporate URL: www.chemogenicsbiopharma.com
- Estimated Number of Employees: 3
- Estimated Annual Receipts: $840,000
- Business Start Date: 2008
- Contact Person: Francis Tavares
- Contact Phone: 919-308-1341
- Contact Email: francis@cgbiopharma.com
- Business Structure:
- Partnership or Limited Liability Partnership
- Business Type:
- For Profit Organization
- Limited Liability f
- Industries Served: Research and Development in Biotechnology, Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Product Areas: DRUGS AND BIOLOGICALS, CHEMICAL ANALYSIS INSTRUMENTS, LIFE SCIENCES (BASIC), R&D- GENERAL SCIENCE/TECHNOLOGY: LIFE SCIENCES (BASIC RESEARCH), R&D- GENERAL SCIENCE/TECHNOLOGY: LIFE SCIENCES (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT), LIFE SCIENCES (APPLIED/EXPLORATORY), HEALTH SERVICES (BASIC), R&D- MEDICAL: HEALTH SERVICES (BASIC RESEARCH), R&D-HEALTH SVCS-A RES/EXPL DEV, R&D- MEDICAL: HEALTH SERVICES (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
Sampling of Federal Government Funding Actions/Set Asides
In order by amount of set aside monies.
- $6,715 - Saturday the 1st of December 2012
National Institutes Of Health
NIH, NHLBI, DERA OA OFC ACQUISTIONS
IGF::OT::IGF 3. OTHER FUNCTION:CHEMOGENICS BIOPHARMA-STUDY-CALIBRATION CURVES FOR PLASMA&BRAIN FOLLOWED W/ QUANTIFICATION OF THE COMPOUND IN SAME TISSUES-SAMPLES: 60 -JUAN MARUGAN/SAM PATNAIK 9800B MCD RM 2B2 ROCKVILLE MD 20850
© Copyright 2019
The Collier Report published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources.
No reliance should be made by readers or Collier Report subscribers.
Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances.
Requests for the modification of displayed information may be made to help.desk@1918.media.